investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Alternative Mechanisms to Inactivate p53 during Oncogenesis
Zhiyuan Shen
1 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Yuntao Xie
Beijing Cancer Hospital
Beijing, China
Zhiyuan Shen
Rutgers University
New Brunswick, United States
Related projects
Dario Marchetti
Heparanase Mechanisms in Brain-metastatic Breast Cancer
Breast
Michael Girardi
Local Immunoregulation of Carcinogenesis
Non-Melanoma skin cancer
Pathology
Sandra Mcallister
Understanding How Breast Cancers Activate and Respond to the Systemic Environment
Breast
Joshua Labaer
Biomarker Detection Using NAPPA Tumor Antigen Arrays
Breast
Mien-Chie Hung
Growth Factor Receptor in Breast Cancer Progression and Metabolic Regulation
Breast
John S Condeelis
Motility and Invasion
Breast
Lalage Wakefield
Development of TGF-beta antagonists for cancer therapy
Breast
Timothy An-Thy Chan
Role of Parkinsons disease gene PARK2 in GBM oncogenesis and genomic instability
Brain, nervous system
Etty N Benveniste
Targeting the JAK/STAT-3 Pathway Signaling Axis in Glioma
Brain, nervous system
Radiation Oncology